Stephen Cleary

852 total citations
18 papers, 681 citations indexed

About

Stephen Cleary is a scholar working on Pathology and Forensic Medicine, Surgery and Oncology. According to data from OpenAlex, Stephen Cleary has authored 18 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Stephen Cleary's work include Intraperitoneal and Appendiceal Malignancies (6 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Ovarian cancer diagnosis and treatment (4 papers). Stephen Cleary is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (6 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Ovarian cancer diagnosis and treatment (4 papers). Stephen Cleary collaborates with scholars based in United States, Denmark and Ireland. Stephen Cleary's co-authors include Stephen B. Howell, Maurie Markman, William E. Lucas, Maurie Markman, Solomon Zimm, Regis J. Weiss, C E Pfeifle, Ian Abramson, Thomas Chan and Paul A. Andrews and has published in prestigious journals such as Journal of Clinical Oncology, Water Research and Cancer.

In The Last Decade

Stephen Cleary

18 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Cleary United States 15 341 236 179 158 98 18 681
Silvio Rea Italy 17 219 0.6× 210 0.9× 375 2.1× 184 1.2× 61 0.6× 72 875
Irene Thomassen Netherlands 9 568 1.7× 165 0.7× 216 1.2× 280 1.8× 31 0.3× 17 858
C Scarabelli Italy 11 473 1.4× 664 2.8× 311 1.7× 82 0.5× 82 0.8× 39 967
Kurt Van der Speeten Belgium 22 1.1k 3.3× 515 2.2× 194 1.1× 234 1.5× 50 0.5× 55 1.4k
Ikuo Joja Japan 19 126 0.4× 388 1.6× 42 0.2× 72 0.5× 28 0.3× 40 825
Yong Jung Song South Korea 18 341 1.0× 384 1.6× 247 1.4× 212 1.3× 45 0.5× 76 1.0k
Aspasia Soultati Greece 12 182 0.5× 54 0.2× 111 0.6× 167 1.1× 60 0.6× 28 589
Daniel S. Metzinger United States 14 344 1.0× 591 2.5× 93 0.5× 194 1.2× 43 0.4× 33 1.1k
Edward S. Greenwald United States 13 127 0.4× 151 0.6× 176 1.0× 111 0.7× 76 0.8× 22 455
Antonio Daniele Pinna Italy 20 806 2.4× 110 0.5× 348 1.9× 401 2.5× 39 0.4× 51 1.0k

Countries citing papers authored by Stephen Cleary

Since Specialization
Citations

This map shows the geographic impact of Stephen Cleary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Cleary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Cleary more than expected).

Fields of papers citing papers by Stephen Cleary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Cleary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Cleary. The network helps show where Stephen Cleary may publish in the future.

Co-authorship network of co-authors of Stephen Cleary

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Cleary. A scholar is included among the top collaborators of Stephen Cleary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Cleary. Stephen Cleary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
O’Donoghue, Gráinne, Aileen Kennedy, Gregers S. Andersen, et al.. (2019). Phenotypic Responses to a Lifestyle Intervention Do Not Account for Inter-Individual Variability in Glucose Tolerance for Individuals at High Risk of Type 2 Diabetes. Frontiers in Physiology. 10. 317–317. 16 indexed citations
2.
Karanicolas, Paul J., Peter Metrakos, Kelvin Chan, et al.. (2013). Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement. Current Oncology. 21(1). 129–129. 44 indexed citations
3.
McGrath, John W., et al.. (2001). Acid-stimulated phosphate uptake by activated sludge microorganisms under aerobic laboratory conditions. Water Research. 35(18). 4317–4322. 18 indexed citations
4.
Goel, Rakesh, Stephen Cleary, Frank M. Balis, et al.. (1989). Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole.. Journal of Clinical Oncology. 7(2). 262–269. 17 indexed citations
5.
Zimm, Solomon, et al.. (1988). Phase I/pharmacokinetic study of thioguanine administered as a 48-hour continuous intraperitoneal infusion.. Journal of Clinical Oncology. 6(4). 696–700. 6 indexed citations
6.
Chan, Thomas, Gordon L. Coppoc, Solomon Zimm, Stephen Cleary, & Stephen B. Howell. (1988). Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patients.. PubMed. 48(1). 215–8. 13 indexed citations
7.
Howell, Stephen B., Solomon Zimm, Maurie Markman, et al.. (1987). Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy.. Journal of Clinical Oncology. 5(10). 1607–1612. 178 indexed citations
8.
Markman, Maurie, Thomas Chan, Stephen Cleary, & Stephen B. Howell. (1987). Phase I trial of combination therapy of cancer with N-phosphanacetyl-L-aspartic acid and dipyridamole. Cancer Chemotherapy and Pharmacology. 19(1). 80–83. 19 indexed citations
9.
Zimm, Solomon, Stephen Cleary, William E. Lucas, et al.. (1987). Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide.. PubMed. 47(6). 1712–6. 70 indexed citations
10.
Markman, Maurie, et al.. (1986). Complications of extensive adhesion formation after intraperitoneal chemotherapy.. PubMed. 162(5). 445–8. 34 indexed citations
11.
Markman, Maurie, Stephen Cleary, C E Pfeifle, & Stephen B. Howell. (1986). Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma. Cancer. 58(1). 18–21. 73 indexed citations
12.
Markman, Maurie, Stephen Cleary, & Stephen B. Howell. (1986). Hypomagnesemia Following High-Dose Intracavitary Cisplatin with Systemically Administered Sodium Thiosulfate. American Journal of Clinical Oncology. 9(5). 440–443. 6 indexed citations
13.
Chan, Thomas, Maurie Markman, Stephen Cleary, & Stephen B. Howell. (1986). Plasma uridine changes in cancer patients treated with the combination of dipyridamole and N-phosphonacetyl-L-aspartate.. PubMed. 46(6). 3168–72. 24 indexed citations
14.
Markman, M, Stephen Cleary, William E. Lucas, Regis J. Weiss, & Howell Sb. (1986). Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycin.. PubMed. 70(6). 755–60. 14 indexed citations
15.
Markman, Maurie, et al.. (1985). Cisplatin and cytarabine administered intrapleurally as treatment of malignant pleural effusions. Medical and Pediatric Oncology. 13(4). 191–193. 26 indexed citations
16.
Markman, Maurie, Stephen Cleary, & Stephen B. Howell. (1985). Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protection. European Journal of Cancer and Clinical Oncology. 21(9). 1015–1018. 39 indexed citations
17.
Markman, Maurie, Stephen Cleary, William E. Lucas, & Stephen B. Howell. (1985). Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity.. Journal of Clinical Oncology. 3(7). 925–931. 50 indexed citations
18.
Markman, Maurie, Stephen Cleary, C E Pfeifle, & Stephen B. Howell. (1985). High-dose intracavitary cisplatin with intravenous thiosulfate. Low incidence of serious neurotoxicity. Cancer. 56(10). 2364–2368. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvio Rea Breakdown of academic impact, for papers by Irene Thomassen Breakdown of academic impact, for papers by C Scarabelli Breakdown of academic impact, for papers by Kurt Van der Speeten Breakdown of academic impact, for papers by Ikuo Joja Breakdown of academic impact, for papers by Yong Jung Song Breakdown of academic impact, for papers by Aspasia Soultati Breakdown of academic impact, for papers by Daniel S. Metzinger Breakdown of academic impact, for papers by Edward S. Greenwald Breakdown of academic impact, for papers by Antonio Daniele Pinna
Rankless by CCL
2026